Trending
May 25, 2022 TARGAN Secures $35M Series C Financing Led by Mountain Group Partners and NovaQuest Capital ManagementMay 23, 2022 Interview with Jan De Backer, CEO of FluiddaMay 20, 2022 Inceptor Bio Raises $37 Million in Series AMay 16, 2022 Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for $337.5 Million plus RoyaltiesMay 16, 2022 Kriya Announces $270 Million Series C Financing
Featured
May 25, 2022
TARGAN Secures $35M Series C Financing Led by Mountain Group Partners and NovaQuest Capital Management
TARGAN announced today it has secured $35 million of Series C equity financing. The financing was co-led by Mountain... Read more »
May 23, 2022
Interview with Jan De Backer, CEO of Fluidda
Jan De Backer is founder and CEO of FLUIDDA, the world leader in the field of Functional Respiratory Imaging (FRI)... Read more »
May 20, 2022
Inceptor Bio Raises $37 Million in Series A
Inceptor Bio, a Morrisville, NC-based biotechnology company focused on cell therapies, raised $37M in Series A funding... Read more »
May 16, 2022
Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for $337.5 Million plus Royalties
